Michael Dean
Branch Chief and Senior Investigator
Division of Cancer Epidemiology & Genetics, Laboratory of Tr
National Cancer Institute
United States of America
Biography
Dr. Michael Dean is the Chief of the Laboratory of Translational Genomics. He obtained his Ph.D. from the Biochemistry Department at the Boston University School of Medicine. He performed his postdoctoral studies at the National Cancer Institute, Center for Cancer Research (CCR), on the MET oncogene and cystic fibrosis gene. He is a member of the American Society of Human Genetics, Centre d'Etude du Polymorphisme Humaine (CEPH), the Human Genome Organization (HUGO), and an adjunct faculty member at Hood College. Before joining DCEG in 2015, Dr. Dean led the Human Genetics Section of the Cancer and Inflammation Program within CCR.
Research Interest
Association to Function; Tumor Genomes; Health Disparities; Global Health and Cancer
Publications
-
Nickerson ML, Das S, Im KM, Turan S, Berndt SI, Li H, Lou H, Brodie SA, Billaud JN, Zhang T, Bouk AJ. TET2 binds the androgen receptor and loss is associated with prostate cancer. Oncogene. 2017 Apr;36(15):2172.
-
Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke A, Ferreccio C. Association of Aflatoxin and Gallbladder Cancer. Gastroenterology. 2017 Apr 17.
-
Yang XR, Devi B, Sung H, Guida J, Xiao Y, Garland L, Hu N, Rodriguez-Herrera M, Wang C, Jones K, Luo W. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
